Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury:: Comparison with brain-derived neurotrophic factor and the induction of neuronal cell death

被引:77
|
作者
Skoglösa, Y
Lewén, A
Takei, N
Hillered, L
Lindholm, D
机构
[1] Biomed Ctr, Dept Neurosci Dev Neurobiol, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Neurosci Neurosurg, Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Med Clin Chem, Uppsala, Sweden
关键词
brain trauma; gene regulation; PACAP; BDNF; in situ hybridization; cell death;
D O I
10.1016/S0306-4522(98)00414-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurotrophic factors are known to promote neuronal survival during development and after acute brain injury. Recent data suggest that some neuropeptides also exhibit neurotrophic activities, as shown for the pituitary adenylate cyclase activating polypeptide, which increases the survival of various neuronal populations in culture. Employing in situ hybridization techniques, we have studied the regulation of messenger RNA for pituitary adenylate cyclase activating polypeptide and its receptor type 1 after a moderate traumatic brain injury to rat brain cortex. We have further compared their messenger RNA expression to that of brain-derived neurotrophic factor and to the amount of cell death occurring in the brain at various times after the brain injury. Levels of brain-derived neurotrophic factor messenger RNA increased rapidly within 2 h after trauma in cortex and hippocampus, and returned to control levels thereafter. The levels of messenger RNA for pituitary adenylate cyclase activating polypeptide also increased with time in the injured brains and reached maximal expression at 72 h, i.e. the end of the observation period. The alterations in pituitary adenylate cyclase activating polypeptide messenger RNA levels were particularly pronounced in the perifocal region and in the ipsilateral dentate gyrus of the brain injury. In contrast, the messenger RNA levels encoding pituitary adenylate cyclase activating polypeptide receptor type 1 first decreased after trauma and were then normalized in the dentate gyrus. There was a large increase in the number of cells labelled for DNA breaks at 12 h past-trauma, indicative of enhanced cell death. The number of labelled cells, however, decreased at later stages concomitant with an increase in the expression of pituitary adenylate cyclase activating polypeptide messenger RNA. Pituitary adenylate cyclase activating polypeptide rescued cortical neurons in cultures against ionomycin-induced cell death, supporting the concept of a neuroprotective effect for the peptide. These results demonstrate a differential regulation of messenger RNA for brain-derived neurotrophic factor and the pituitary adenylate cyclase activating polypeptide and its receptor after brain trauma. The data also suggest that pituitary adenylate cyclase activating polypeptide might have a beneficial effect in brain injury by counteracting neuronal cell death. (C) 1999 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:235 / 247
页数:13
相关论文
共 50 条
  • [1] Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor
    Zink, M
    Otto, C
    Zörner, B
    Zacher, C
    Schütz, G
    Henn, FA
    Gass, P
    NEUROSCIENCE LETTERS, 2004, 360 (1-2) : 106 - 108
  • [2] Developmental regulation of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor 1 in rat brain:: Function of PACAP as a neurotrophic factor
    Lindholm, D
    Skoglösa, Y
    Takei, N
    VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM, 1998, 865 : 189 - 196
  • [3] Pituitary adenylate cyclase-activating polypeptide regulates brain-derived neurotrophic factor exon IV expression through the VPAC1 receptor in the amphibian melanotrope cell
    Kidane, Adhanet H.
    Roubos, Eric W.
    Jenks, Bruce G.
    ENDOCRINOLOGY, 2008, 149 (08) : 4177 - 4182
  • [4] Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury
    Farkas, O
    Tamás, A
    Zsombok, A
    Reglödi, D
    Pál, J
    Büki, A
    Lengvári, I
    Povlishock, JT
    Dóczi, T
    REGULATORY PEPTIDES, 2004, 123 (1-3) : 69 - 75
  • [5] Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain
    Peeters, K
    Gerets, HHJ
    Arckens, L
    Vandesande, F
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 423 (01) : 66 - 82
  • [6] Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain
    Shuto, Y
    Uchida, D
    Onda, H
    Arimura, A
    REGULATORY PEPTIDES, 1996, 67 (02) : 79 - 83
  • [7] Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury
    Chen, WH
    Tzeng, SF
    NEUROSCIENCE LETTERS, 2005, 384 (1-2) : 117 - 121
  • [8] Plasma brain-derived neurotrophic factor levels after severe traumatic brain injury
    Simon, Daniel
    Moreira do Nascimento, Rita Iara
    Rodrigues Filho, Edison Moraes
    Bencke, Jane
    Regner, Andrea
    BRAIN INJURY, 2016, 30 (01) : 23 - 28
  • [9] Expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) specific receptor (PAC1R) after traumatic brain injury in mice
    Morikawa, Kentaro
    Dohi, Kenji
    Yofu, Sachiko
    Mihara, Yuko
    Nakamachi, Tomoya
    Ohtaki, Hirokazu
    Shioda, Seiji
    Aruga, Tohru
    TRANSMITTERS AND MODULATORS IN HEALTH AND DISEASE: NEW FRONTIERS IN NEUROSCIENCE, 2009, : 207 - +
  • [10] Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone
    Furukawa, S
    Nitta, A
    NEURAL DEVELOPMENT-BOOK, 1999, 2 : 159 - 164